Bristol-Myers Squibb Co. (BMY): Price and Financial Metrics

BMY POWR Grades

• Value is the dimension where BMY ranks best; there it ranks ahead of 98.19% of US stocks.
• BMY's strongest trending metric is Growth; it's been moving up over the last 179 days.
• BMY's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

BMY Stock Summary

• With a market capitalization of $159,620,369,809, Bristol Myers Squibb Co has a greater market value than 98.56% of US stocks.
• Bristol Myers Squibb Co's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
• In terms of twelve month growth in earnings before interest and taxes, Bristol Myers Squibb Co is reporting a growth rate of -217.22%; that's higher than merely 9.05% of US stocks.
• If you're looking for stocks that are quantitatively similar to Bristol Myers Squibb Co, a group of peers worth examining would be AMGN, NVS, SNY, RTX, and TXN.
• BMY's SEC filings can be seen here. And to visit Bristol Myers Squibb Co's official web site, go to www.bms.com.

BMY Valuation Summary

• BMY's EV/EBIT ratio is -44.2; this is 250.85% lower than that of the median Healthcare stock.
• Over the past 243 months, BMY's price/sales ratio has gone down 2.6.
• BMY's price/sales ratio has moved down 2.6 over the prior 243 months.

Below are key valuation metrics over time for BMY.

BMY Growth Metrics

Its 5 year revenue growth rate is now at 83.36%.
• Its 3 year net cashflow from operations growth rate is now at 650.61%.
• The 2 year net income to common stockholders growth rate now stands at 3.81%.

Over the past 34 months, BMY's revenue has gone up $23,097,000,000.

The table below shows BMY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	46,385	16,207	6,994
2021-09-30	45,468	15,820	-5,405
2021-06-30	44,384	12,773	-5,079
2021-03-31	42,810	13,982	-6,219
2020-12-31	42,518	14,052	-9,015
2020-09-30	39,395	12,420	-44

BMY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BMY has a Quality Grade of B, ranking ahead of 79.64% of graded US stocks.
• BMY's asset turnover comes in at 0.38 -- ranking 124th of 680 Pharmaceutical Products stocks.
• PAHC, ACUR, and XLRN are the stocks whose asset turnover ratios are most correlated with BMY.

The table below shows BMY's key quality metrics over time.